Stock Analysis
Data Source: SEC EDGAR 13F
Updated Hourly

GAIN THERAPEUTICS INC (GANX)

40 + Investors. Track Smart Money conviction in GANX. See who's accumulating, reducing, or initiating positions.

Fetching live quote...
Current Price
-- USD
Analyst Target
-- (0 analysts)
Upside
0.00%
Net Flow Q/Q
↓ -9
Streak
1Q ▼
Buyers last Q
40%

Smart Money Signals — GANX

Based on 40 hedge funds · latest filing: 2026 Q1 · updated quarterly

📉

Selling streak — 1 quarter in a row

last 6Q
For 1 consecutive quarter, more hedge funds reduced or closed their GANX positions than added to them. Sustained institutional selling is a meaningful warning sign — these are professionals with deep research teams collectively deciding to exit.
📊

High ownership — 82% of 3.0Y peak

82% of all-time peak
40 funds currently hold this stock — 82% of the 3.0-year high of 49 funds (reached 2025 Q4). Ownership is elevated but not yet at maximum concentration. Room to grow, but watch if the trend reverses.
🚀

Fast accumulation — +21% more funds vs a year ago

fund count last 6Q
+7 new funds entered over the past year (+21% YoY). That's a rapid rush of institutional money. Fast accumulation often signals a major thesis — but it also means the stock could fall quickly if that thesis breaks.
🟠

More sellers than buyers — 40% buying

18 buying27 selling
Last quarter: 27 funds reduced or exited vs 18 that bought or added. When more than half of active funds are selling, it's a caution flag — especially if the stock price hasn't moved down yet.
⚠️

Fewer new buyers each quarter (-14 vs last Q)

new funds entering per quarter
Funds opening this position for the first time: 6 → 9 → 21 → 7. Each quarter fewer new institutions are entering. This usually means most funds that wanted in are already in — the stock is well-known but the pool of potential new buyers is shrinking.
📌

Mixed — 35% long-term, 42% new

35% conviction (2yr+) 22% medium 42% new
Of the 40 current holders: 14 (35%) held >2 years, 9 held 1–2 years, and 17 entered in the last year. A mixed base — the stock has long-term believers but also recent buyers who haven't been tested by a downturn yet.
💎

Buying through price weakness — shares +1%, value -46%

Value
-45%
Shares
+1%
Last quarter: funds added +1% more shares while total portfolio value only changed -46%. Institutions were buying while the price was falling — a high-conviction accumulation signal. They're deliberately loading up on the dip.
➡️

Steady discovery — ~7 new funds/quarter

10 → 6 → 9 → 21 → 7 new funds/Q
New funds entering each quarter: 6 → 9 → 21 → 7. Consistent flow of new institutional buyers without clear acceleration or slowdown.
🏛️

Deep conviction — 41% of holders stayed 2+ years

41% veterans 23% 1-2yr 36% new
Of 44 current holders: 18 (41%) have held for over 2 years without selling. These are not momentum buyers — they have lived through drawdowns and stayed. A large veteran base acts as a stabilizing force during selloffs.

Strong quality — 35% AUM from major funds

35% from top-100 AUM funds
13 of 40 holders rank in the top 100 by AUM, accounting for 35% of total institutional value held. A meaningful share of the ownership value comes from the most well-resourced institutions.
4.2
out of 10
Moderate Exit Risk
Exit risk score 4.2/10 — some crowding factors present, but no critical concentration. Watch ownership trend over the next 1–2 quarters for direction.

Methodology note: these Smart Money cards use consecutive 13F disclosure snapshots, not trade-by-trade execution data. "Buying", "selling", "new holders", and "trimmed" refer to quarter-over-quarter changes in reported holders, aggregate shares, or disclosed position values between filings. They are useful for ownership regime analysis and crowding, but they do not imply exact trade timing on the filing date.

Institutional Sentiment Summary — GANX

In 2026 Q1, 18 hedge funds were net buyers of GANX (7 opened a new position, 11 added to an existing one), while 27 reduced or exited (11 trimmed, 16 sold completely) — a 40% buyer ratio, indicating roughly balanced activity. 35% of total institutional value in GANX is held by top-100 AUM funds, reflecting strong institutional quality. Net fund flow last quarter: -9 funds (more exits than new entries). Total institutional holders: 40.

Hedge Fund Ownership: GANX

How many hedge funds hold GANX — quarterly history vs. share price
Quarterly hedge fund ownership of GANX vs. share price

Market Analysis: GANX

Analyst Price Targets

Avg. Price Target
--

Analyst Recommendations

Stock Performance

Real-time

Company Profile: GANX

-- --

Institutional ownership data sourced from SEC EDGAR Form 13F-HR filings.

Is It Too Late to Buy GAIN THERAPEUTICS INC (GANX) Based on Hedge Fund 13F Filings?

Signal Freshness measures how much GANX has moved relative to its sector benchmark (XLV) since the 2026 Q1 13F filing. A stock that has barely outrun its sector is still a relatively fresh entry point — the fund's thesis has not yet been priced in by the broader market.

Since Quarter End March 31, 2026 · 51d ago
GANX
-4.0%
XLV
+352.2%

GANX outperformed XLV by -356.2% since March 31, 2026.

Since 13F Filing Date May 15, 2026 · 6d ago
GANX
-5.7%
XLV
+386.1%

Since the filing became public, GANX outperformed XLV by -391.8% .

Interpretation: The stock is tracking its sector benchmark closely. The signal remains fresh and the entry point is still near the fund's implied reference. Learn more →

Smart Money Signal ?
Limited Smart Money Interest

No strong consensus or elite conviction detected among institutional holders.

4 top-rated funds 0 high-conviction
Consensus
3.0
/ 10
breadth
×
Elite
0.1
/ 10
conviction
Hedge Fund Positioning: GANX
40 + Investors

Track Smart Money conviction in GANX. See who's accumulating, reducing, or initiating positions.

Metric All 13F Filers (2026 Q1) Prior (2025 Q4) Change
Funds Holding 40 49 -18.37%
13F Shares 8M 8M 1.43%
Total Value $14M $26M -45.73%
New Positions 7 21 -14
Increased Positions 10 15 -5
Closed Positions 16 10 +6
Reduced Positions 10 4 +6
Total Calls 3 2 50.0%
Total Puts 1 2 -50.0%
PUT/CALL Ratio 0.33 1.0 Bullish

Statistics: GANX

View More

Valuation Measures Data as of: --

Market Cap --
Enterprise Value --
Trailing P/E --
Forward P/E --
PEG Ratio (5yr expected) --
Price/Sales (ttm) --
Price/Book (mrq) --
Enterprise Value/Revenue --
Enterprise Value/EBITDA --
Beta (5Y Monthly) --
Short Ratio (Days to Cover) --
Short % of Float --

Financial Highlights

Profitability
Profit Margin --
Return on Assets (ttm) --
Return on Equity (ttm) --
Income Statement & Cash Flow
Revenue (ttm) --
Net Income Avi to Common (ttm) --
Diluted EPS (ttm) --
Total Cash (mrq) --
Total Debt/Equity (mrq) --
Levered Free Cash Flow (ttm) --

Institutional Holders (2026 Q1)

40 + investors

Explore institutional interest and hedge fund ownership dynamics. Analyze portfolio weights, new positions, and conviction trends in GANX. Verified SEC 13F-HR filings.

QUARTER:
Top 25 institutional holders of GANX — 2026 Q1 · Source: SEC Form 13F
# Investor % of Portfolio Shares Mkt Value
1 Potomac Capital Management, Inc. 1.70% 1,008,600 $2.0M
2 GSA CAPITAL PARTNERS LLP 0.04% 312,467
3 DME Capital Management, LP 0.03% 566,130 $1.1M
4 Millington Financial Advisors, LLC 0.01% 15,000 $29K
5 BENEDICT FINANCIAL ADVISORS INC 0.01% 15,500 $30K
6 Oliver Luxxe Assets LLC 0.01% 20,250 $39K
7 PRELUDE CAPITAL MANAGEMENT, LLC 0.01% 35,820 $69K
8 MARSHALL WACE, LLP 0.00% 1,769,788 $3.4M
9 Stratos Wealth Partners, LTD. 0.00% 131,621 $255K
10 Cambridge Investment Research Advisors, Inc. 0.00% 568,645 $1K
11 Sandhill Capital Partners LLC 0.00% 15,400 $30K
12 Cresset Asset Management, LLC 0.00% 160,000 $310K
13 BRIDGEWAY CAPITAL MANAGEMENT, LLC 0.00% 30,004 $58K
14 Virtu Financial LLC 0.00% 10,685
15 Apollon Wealth Management, LLC 0.00% 26,500 $51K
16 JONES FINANCIAL COMPANIES LLLP 0.00% 631,615 $1.2M
17 NewEdge Advisors, LLC 0.00% 10,600 $11K
18 Schonfeld Strategic Advisors LLC 0.00% 24,500 $48K
19 Tower Research Capital LLC (TRC) 0.00% 5,506 $11K
20 Wealthspire Advisors, LLC 0.00% 16,900 $33K
21 VANGUARD FIDUCIARY TRUST CO 0.00% 229,979 $446K
22 SUSQUEHANNA INTERNATIONAL GROUP, LLP 0.00% 431,267 $837K
23 Kestra Advisory Services, LLC 0.00% 12,000 $23K
24 COMMONWEALTH EQUITY SERVICES, LLC 0.00% 29,703 $58K
25 UBS Group AG 0.00% 220,489 $428K
Investor Ownership
History
% of Portfolio Prev % Rank Conviction Avg Buy Price 13F Score™ 3Y / 7Y Sell Timing Shares Mkt Value Change Change % Source Quarter Filed

Frequently Asked Questions — GAIN THERAPEUTICS INC (GANX)

What does the Smart Money Trend signal show for GANX?

Selling streak — 1 quarter in a row: For 1 consecutive quarter, more hedge funds reduced or closed their GANX positions than added to them. Sustained institutional selling is a meaningful warning sign — these are professionals with deep research teams collectively deciding to exit.

What is the institutional breadth score for GANX?

More sellers than buyers — 40% buying: Last quarter: 27 funds reduced or exited vs 18 that bought or added. When more than half of active funds are selling, it's a caution flag — especially if the stock price hasn't moved down yet.

What is the fund quality score for GANX holders?

Strong quality — 35% AUM from major funds: 13 of 40 holders rank in the top 100 by AUM, accounting for 35% of total institutional value held. A meaningful share of the ownership value comes from the most well-resourced institutions.

How long have hedge funds held GANX?

Mixed — 35% long-term, 42% new: Of the 40 current holders: 14 (35%) held >2 years, 9 held 1–2 years, and 17 entered in the last year. A mixed base — the stock has long-term believers but also recent buyers who haven't been tested by a downturn yet.

Is it too late to buy GAIN THERAPEUTICS INC (GANX) following the 2026 Q1 hedge fund 13F filings?

As of today, GANX has moved -5.7% since the 2026 Q1 13F filing date (May 15, 2026), compared to +386.1% for the XLV sector ETF — an outperformance of -391.8%. Since the quarter end (March 31, 2026), GANX has gained -4.0% vs +352.2% for XLV. The stock is tracking its sector benchmark closely. The signal remains fresh and the entry point is still near the fund's implied reference.

Where does this institutional ownership data come from?

All holdings data is sourced from SEC Form 13F filings, which institutional investment managers with over $100 million in assets are required to submit quarterly. Data is parsed directly from SEC EDGAR.

Disclaimer: The information on this page is for informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any security. Institutional holdings data is sourced from SEC Form 13F filings and reflects positions as of the filing date. Past performance of any fund or portfolio is not indicative of future results. 13Foresight is not a registered investment adviser. Always conduct your own due diligence before making investment decisions.

Full history →